Atherosclerosis of Artery Clinical Trial
— ExcellentOfficial title:
Excellent:Clinical Study of Excimer Laser and Drug Coated Balloon Versus Excimer Laser and Plain Balloon Versus Plain Balloon and Drug Coated Balloon to Treat Femoropopliteal In-stent Restenosis
NCT number | NCT04365062 |
Other study ID # | FPA-ISR |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | January 1, 2018 |
Est. completion date | December 2021 |
Verified date | July 2019 |
Source | Xuanwu Hospital, Beijing |
Contact | li yang |
Phone | 17198643706 |
1093075829[@]qq.com | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a randomized study comparing Excimer laser and drug coated balloon Versus Excimer laser and plain balloon versus plain balloon and drug coated balloon to Treat femoropopliteal in-stent restenosis
Status | Recruiting |
Enrollment | 160 |
Est. completion date | December 2021 |
Est. primary completion date | December 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Provides written informed consent Willing to comply with follow-up evaluations at specified times Has claudication or rest pain due to peripheral arterial In-stent restenosis Disease located within the femoropopliteal artery Patient has a In-stent restenosis lesion(s) with >50% stenosis documented angiographically Patient has symptoms of peripheral arterial disease classified as Rutherford Category 2 or greater. Exclusion Criteria: They were excluded if they had one or more of the following: 1. Acute or subacute lower limb ischemia; 2. Severe calcification lesions; 3. Total occlusions lesions more significant than 10 cm or total occlusion lesions with a suspicion of subintimal wire recanalization 4. untreated ipsilateral iliac artery stenosis>70%, or the distal runoff artery <1 root; 5. Previously lower extremity intervention or surgical graft artery bypass; 6. Severe renal insufficiency, creatinine level greater than 2.5 mg/dL; 7. The patient's platelet count is less than 100,000/uL, antiplatelet or anticoagulant contraindications to required medications; 8. Patients with immune system diseases or malignant tumours; 9. ongoing active infection 10. decompensated congestive heart failure or acute coronary syndrome; 11. Unwillingness to return for future follow-up visits |
Country | Name | City | State |
---|---|---|---|
China | Gu Yong Quan | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Xuanwu Hospital, Beijing |
China,
Yongquan G, Lianrui G, Lixing Q, Xuefeng L, Zhu T, Shijun C, Yingfeng W, Jianming G, Jian Z, Zhonggao W. Plaque excision in the management of lower-limb ischemia of atherosclerosis and in-stent restenosis with the SilverHawk atherectomy catheter. Int Angiol. 2013 Aug;32(4):362-7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Primary Patency Rate | Primary patency is defined as no significant reduction of flow detectable by Duplex ultrasound through the index lesion and no further clinically driven target vessel revascularization performed in the interim. Significant reduction of flow is binary restenosis defined as the diameter stenosis >50% with a peak systolic velocity ratio >2.4 as measured by Duplex ultrasound. | 12 months | |
Secondary | Technical success | Technical success is defined as residual stenosis less than 30% by final angiography and/or a flow-limiting dissection. | 1 day | |
Secondary | freedom from clinically-driven TLR | it is defined as freedom from clinically-driven target lesion revascularization | 12 months | |
Secondary | Major Adverse Events | Major adverse events included death, index limb ischemia, index limb amputation, and significant embolic events, which were defined as causing end-organ damage. | 12 months | |
Secondary | Limb Salvage Rate | Limb Salvage is defined as the freedom from secondary major amputation | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
Recruiting |
NCT05680935 -
microRNAs in the Diagnosis of Atherosclerotic Plaque Instability
|
N/A | |
Recruiting |
NCT04955015 -
Associations of Carotid Plaque Characteristics With Brain Perfusion and Cognitive Function in Patients Undergoing CEA
|
||
Recruiting |
NCT06091319 -
Florbetaben for Imaging of Vascular Amyloid
|
||
Recruiting |
NCT06211127 -
Safety and Efficacy of Cold Laser Plaque Ablation for Lower Limb Arterial Stenosis and Occlusive Lesions
|
N/A | |
Withdrawn |
NCT05908513 -
NAC Treatment and Outcomes in Patients With Advanced Atherosclerosis and DM
|
Phase 1 | |
Suspended |
NCT03928769 -
PROGENitors, TELomeres and ARTerial Aging
|
||
Not yet recruiting |
NCT04277702 -
Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
|
Phase 3 | |
Not yet recruiting |
NCT04303546 -
VOPITB a New Devices to Determine Peripheral Arterial Stiffness: Validation Study
|
||
Completed |
NCT05214872 -
The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease
|
||
Completed |
NCT02715830 -
Randomized Clinical Trial in Bellow-the-knee Angioplasty. Treatment of One or More Than One Artery.
|
Phase 4 | |
Not yet recruiting |
NCT06447701 -
Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis
|
Phase 3 | |
Recruiting |
NCT04758650 -
Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis
|
Phase 2 | |
Completed |
NCT04198896 -
The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC)
|
||
Completed |
NCT03499496 -
Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk
|
||
Completed |
NCT05118542 -
Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis
|
Phase 3 | |
Completed |
NCT03962686 -
Molecular Mechanisms and Carotid Atherosclerosis
|
||
Active, not recruiting |
NCT04666584 -
Optimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis
|
N/A | |
Recruiting |
NCT05797376 -
Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
|
Phase 4 | |
Not yet recruiting |
NCT04303351 -
Periodontitis and Atherosclerotic-related Arterial Stenosis
|